H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Cybin (CYBN – Research Report) today and set a price target of $190.00. The ...

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on COMPASS Pathways (CMPS – Research Report) today and set a price target of ...

Protalix BioTherapeutics (NYSE:PLX – Get Free Report) had its price objective increased by HC Wainwright from $10.00 to $15.00 in a report released on Monday,Benzinga reports. The brokerage presently ...

XOMA (NASDAQ:XOMA – Get Free Report) had its price target cut by equities research analysts at HC Wainwright from $123.00 to $104.00 in a research note issued to investors on Monday,Benzinga reports.

We recently compiled a list of the 10 Trending AI Stocks That Analysts Are Monitoring. In this article, we are going to take ...

H.C. Wainwright reaffirmed its Buy rating on Rezolute (NASDAQ:RZLT) with a price target of $14.00. The company, currently trading at $5.50 with a market capitalization of $319 million, has delivered ...

H.C. Wainwright reaffirmed its Buy rating and $26.50 price target for US GoldMining (NYSE:GLDG) Inc. (NASDAQ:USGO) shares. The firm's analysts highlighted the recent advancements in the company's ...

We recently compiled a list of the 10 Trending AI Stocks on Wall Street’s Radar. In this article, we are going to take a look ...

Number 1 Investment Bank for Confidentially Marketed Public Offerings, Registered Direct, Private Placement, and At-the-Market (ATM) Offerings H.C. Wainwright & Co., LLC, announced its #1 Ranking ...

NEW YORK--(BUSINESS WIRE)--H.C. Wainwright & Co., LLC, announced its #1 Ranking by transaction volume for the calendar year of 2024, maintaining the Firm’s top position for 11 consecutive years ...

Number 1 Investment Bank for Confidentially Marketed Public Offerings, Registered Direct, Private Placement, and At-the-Market (ATM) Offerings NEW YORK, January 27, 2025--(BUSINESS WIRE)--H.C.